Global Lennox-Gastaut Syndrome Drug Market Industry Analysis and Forecast 2026

Market Analysis and Insights:-Global Lennox-Gastaut Syndrome Drug Market

Lennox-Gastaut Syndrome Drug Market

Market Analysis: Global Lennox-Gastaut Syndrome Drug Market

Global Lennox-Gastaut syndrome drug market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rising population with risk factors for LGS, the growing prevalence of infectious diseases such as encephalitis and meningitis will further increase the risk of the development of LGS, initiatives taken by government and non-governmental organizations for raising awareness about this syndrome, increasing investment of biotechnology and pharmaceutical industries in R&D and increasing healthcare expenditure are some of the factors fueling the market growth.

Get More Insight About the Global Lennox-Gastaut Syndrome Drug Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lennox-gastaut-syndrome-drug-market


Market Definition: Global Lennox-Gastaut Syndrome Drug Market

Lennox-Gastaut syndrome (LGS) is a rare type of childhood onset epilepsy that progresses during early stages of childhood. Patients with this syndrome have developmental delay, behavioral problems and different types of seizures such as atonic, tonic and atypical absence seizures.

This syndrome is associated with several gene mutations, perinatal insults, congenital infections, brain tumors/malformations and genetic disorders such as tuberous sclerosis and West syndrome.

According to National Organization for Rare Disorders (NORD), it estimates that Lennox-Gastaut syndrome occur in 1-28 people per 100,000 and it accounts for 1-4 percent of all cases of childhood epilepsy. The annual incidence of this syndrome in children is estimated to be 2 per 100,000 children.

Market Drivers

Rising population with risk factors for LGS is driving the market growth

Growing prevalence of infectious diseases such as encephalitis and meningitis increases the risk of the development of LGS which acts as a market driver

Increasing investment of biotechnology and pharmaceutical industries in R&D is enhancing the market growth

Initiatives taken by government and non-governmental organizations for raising awareness amongst people about this disorder also boost the market growth

Increasing global healthcare expenditure drives the market growth


Market Restraints

Side effects associated with available treatment is hampering the market growth

High cost of treatment available is restraining the market growth

Lack of availability of essential services in remote areas acts as a market restraint


Know More About this Report @ https://www.databridgemarketresearch.com/reports/global-lennox-gastaut-syndrome-drug-market


Segmentation: Global Lennox-Gastaut Syndrome Drug Market

By Mechanism of Action

Anti-Epileptics

Anticonvulsants

Others


By Drugs

Valproic Acid

Topiramate

Felbamate

Rufinamide

Lamotrigine

Others


By Treatment

Medication

Dietary Therapy

Surgery


By Route of Administration

Oral

Parenteral


By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy


By End-Users

Hospitals

Homecare

Specialty Clinics


By Geography

North America

U.S.

Canada

Mexico


Europe

Germany

Italy

U.K.

France

Spain

Netherlands

Belgium

Switzerland

Turkey

Russia

Rest of Europe


Asia-Pacific

Japan

China

India

South Korea

Australia

Singapore

Malaysia

Thailand

Indonesia

Philippines

Rest of Asia Pacific


South America

Brazil

Rest of South America


Middle East & Africa

South Africa

Rest of Middle East & Africa



Key Developments in the Market

In November 2018, Aquestive Therapeutics, Inc received the U.S FDA approval for Sympazan (clobazam) for the treatment of Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older. Patients with LGS have difficulty in swallowing tablets or large volumes of oral suspension, because of physical limitations or compliance issues, Sympazan oral film is a cost effective treatment and will overcome difficulties in those patients who faces difficulty in swallowing tablets


In June 2018, GW Pharmaceuticals plc received the U.S FDA approval for Epidiolex (cannabidiol), oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age and older. This approval proves that properly evaluating the active ingredients contained in marijuana can lead to important medical therapies


Competitive Analysis:

Global Lennox-Gastaut syndrome drug market

Key Market Players:

The key market players in the global Lennox-Gastaut syndrome drug market are Pfizer Inc, Sunovion Pharmaceuticals Inc, Novartis AG, Abbott, Eisai Co., Ltd, INSYS THERAPEUTICS, INC, GW Pharmaceuticals plc, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Zogenix, H. Lundbeck A/S, Bausch Health, Supernus Pharmaceuticals, Inc, UCB Pharma Ltd, Sanofi, Marinus Pharmaceuticals, Inc, Teva Pharmaceutical Industries Ltd among others.

Research Methodology: Global Lennox-Gastaut Syndrome Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-lennox-gastaut-syndrome-drug-market


The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Access Full Report @https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-lennox-gastaut-syndrome-drug-market



About Data Bridge Market Research:

Data Bridge Market Research


Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Follow
4.7 Star App Store Review!
Cpl.dev***uke
The Communities are great you rarely see anyone get in to an argument :)
king***ing
Love Love LOVE
Download

Select Collections